Expanding Covid-19 diagnostics product portfolio

Recombinant SARS-CoV-2 Nucleocapsid Protein

Recombinant SARS-CoV-2 Nucleocapsid Protein

As a part of our expanding Covid-19 diagnostics product portfolio, Medix Biochemica announces the availability of recombinant SARS-CoV-2 nucleocapsid protein to support diagnostic test manufacturers globally. As it is expressed in CHO cells, it provides highest quality and performance.

The novel SARS-CoV-2 N antigen can be used with well validated anti-IgG and anti-IgM antibodies in serological testing to detect SARS-CoV-2 antibodies from blood samples.

Ordering information

Biological materials

In addition, patient serum and nasal swab samples, and other Covid-19 relevant biological materials are available in our portfolio, including:

  • Covid-19 positive serum samples
  • Covid-19 negative serum samples
  • Covid-19 positive nasal swabs
  • Covid-19 negative nasal swabs
  • Other relevant biological materials

Please visit www.leebio.com to find out more about these products.

For further information, you can get in touch with our Technical Support: moc.acimehcoibxidem@troppushcet